GLUE
#2362
Monte Rosa Therapeutics, Inc. - Common Stock
13.6 6 USD
-0.05%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-4.61%
Monthly Change
-38.55%
6 month change
-20.63%
Year Change
+20.88%
Previous Close
14.3 2
Open
13.6 7
Low
13.6 3
High
13.7 5
Volume
199
Financials
- Market Capitalization 1.17 B
- Employee 173
- Founded 2019
- CEO N/A
- Website www.monterosatx.com
- Headquarter Delaware, United States
- FIGI BBG00X2VGZQ3
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-33.72
Price to sales ratio
10.53
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2350 |  CRVS Corvus Pharmaceuticals, Inc. - Common Stock | 14.15 USD | -3.87% | -2.14% | +5.91% | +161.07% | 1.19 B USD | ||
| 2353 |  SANA Sana Biotechnology, Inc. - Common Stock | 3.93 USD | -3.91% | +0.51% | +19.82% | +29.70% | 1.18 B USD | ||
| 2380 |  KURA Kura Oncology, Inc. - Common Stock | 12.64 USD | -4.10% | +6.31% | +36.21% | +55.47% | 1.12 B USD | ||
| 2397 |  JANX Janux Therapeutics, Inc. - Common Stock | 18.01 USD | -4.10% | +3.57% | +20.71% | -22.03% | 1.10 B USD |
Frequently asked questions about Monte Rosa Therapeutics, Inc. Common Stock
What is the Monte Rosa Therapeutics, Inc. Common Stock stock price today?
The current price of Monte Rosa Therapeutics, Inc. Common Stock (GLUE) is 13.66. Over the past 24 hours, the stock has changed by -4.61%. Follow the GLUE chart for real-time price dynamics.
What is the stock ticker of Monte Rosa Therapeutics, Inc. Common Stock?
Monte Rosa Therapeutics, Inc. Common Stock trades under the ticker GLUE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Monte Rosa Therapeutics, Inc. Common Stock stock going up?
GLUE has changed by -6.37% over the last week, -38.55% over the last month, and +20.88% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Monte Rosa Therapeutics, Inc. Common Stock?
Monte Rosa Therapeutics, Inc. Common Stock currently has a market capitalization of 1.17 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Monte Rosa Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Monte Rosa Therapeutics, Inc. Common Stock reported earnings of -0.43 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Monte Rosa Therapeutics, Inc. Common Stock revenue for the last quarter?
Monte Rosa Therapeutics, Inc. Common Stock reported quarterly revenue of 8.97 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Monte Rosa Therapeutics, Inc. Common Stock net income for the last quarter?
Monte Rosa Therapeutics, Inc. Common Stock reported net income of -43.4 M for the last quarter. The previous quarter showed -44.5 M, which means net income changed by +2.49%.
How many employees does Monte Rosa Therapeutics, Inc. Common Stock have?
As of the latest available data, Monte Rosa Therapeutics, Inc. Common Stock has 173 employees. Workforce size can provide additional context about the company's scale and operations.
What is Monte Rosa Therapeutics, Inc. Common Stock EBITDA?
Monte Rosa Therapeutics, Inc. Common Stock EBITDA is -46.51 M, and its EBITDA margin is -518.63%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Monte Rosa Therapeutics, Inc. Common Stock stock?
You can buy Monte Rosa Therapeutics, Inc. Common Stock (GLUE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Monte Rosa Therapeutics, Inc. Common Stock stock?
Investing in Monte Rosa Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the GLUE chart and related analysis on metatrader.com as part of your research.